ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Mar 16, 2023 10:00 JST
Source:
Avantor
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables
Singapore, Mar 16, 2023 - (ACN Newswire) - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA).
Narayana Rao Rapolu, Vice President - Biopharma AMEA and General Manager, SEAT (left) receiving the award from Dr Wei Kuang Chi (right) Distinguished Consultant, Development Center for Biotechnology
The award recognizes Avantor's ongoing efforts to provide innovative chromatography solutions that enable biopharmaceutical manufacturers to optimize processes and enhance product quality. With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
"Chromatography is one of the most important components in enabling scientific breakthroughs and bringing promising biologics to market effectively. This award is a testament to our commitment to developing and delivering innovative solutions that help our customers optimize their bioprocessing operations," said Narayana Rao Rapolu, Vice President - Biopharma AMEA and General Manager, South East Asia & Taiwan (SEAT) at Avantor. "Our chromatography solutions can play a critical role in supporting biopharmaceutical manufacturers' acceleration of their drug development timelines and improving the quality of their products."
"We are exceptionally proud to have been selected by the panel of industry experts and honored at this year's ceremony as the Best Bioprocessing Company - Chromatography. Avantor's chromatography solutions have demonstrated innovation and effectiveness in addressing the challenges faced by biopharmaceutical manufacturers, and we are excited to see the continued impact of these solutions in the industry," said Christophe Couturier, Executive Vice President of Asia, Middle East & Africa.
About Avantor
Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn (www.linkedin.com/company/avantorinc/, Twitter (
https://twitter.com/Avantor_News
) and Facebook (www.facebook.com/Avantorinc/).
About Asia Pacific Bioprocessing Excellence Awards (ABEA)
The Asia-Pacific Bioprocessing Excellence Awards (ABEA) seeks to give recognition to exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill & finish experts, organizations and technologies over the past year. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.
Regional Media Contact
Christina Koh
Director, Communications - AMEA
Avantor
M: +65 9720 0169
Christina.Koh@avantorsciences.com
SOURCE:
https://bit.ly/3yMsNic
Source: Avantor
Sectors: Daily News, BioTech, Healthcare & Pharm, Local Biz, MedTech
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works
Dec 08, 2025 17:00 JST
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST
MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST
World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST
Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST
Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
More Latest Release >>
Related Release
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
July 24 2025 09:00 JST
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
April 03 2025 17:00 JST
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
August 23 2024 08:00 JST
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
March 21 2024 09:00 JST
Avantor Inaugurates Expanded Singapore Hub
July 11 2023 13:00 JST
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition
April 03 2023 12:00 JST
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
August 24 2022 07:55 JST
Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
June 30 2022 10:42 JST
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
May 05 2022 04:05 JST
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
December 06 2021 10:00 JST
More Press release >>